NF-κB activation promotes the maintenance of GBM-stem-like cells therefore suggesting an impact on GBM resistance to radiotherapy by increasing the percentage of stem-like behavior in cancer cells[60]. This evidence concerns the gene NFKB1 and glioblastoma.